In This Section

Program

Wednesday, September 29, 2021

Thursday, September 30, 2021

Wednesday, September 29

Opening Session
10-10:45 a.m.

Welcome from Cochairs

Welcome from Lead Supporters
Lustgarten Foundation 

Rising Star Keynote
Molecular subtypes and vulnerabilities in pancreatic cancer
Andrew J. Aguirre, Dana-Farber Cancer Institute, Boston, Massachusetts

Break
10:45-11 a.m.
Session 1: Immunotherapy Translation in Progress
Moderator: Robert H. Vonderheide, Penn Medicine Abramson Cancer Center, Philadelphia, Pennsylvania
11 a.m.-12:45 p.m.

Session Keynote
Title to be announced
David G. DeNardo, Washington University School of Medicine, St. Louis, Missouri

Four short talks from proffered abstracts

Discussant: Reginald Hill, Ellison Institute for Transformative Medicine of USC, Los Angeles, California

Discussion

Break
12:45-1:15 p.m.
Career Breakout Rooms
1:15-2 p.m.

Transitioning from Academics to Industry

David J. Shields, Pfizer, New York, New York
Christina Twyman-Saint Victor, Bristol-Myers Squibb, Piscataway, New Jersey


Collaborating with Industry

Channing Der, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Additional mentor to be announced


Starting Your Lab

Yuliya Pylayeva-Gupta, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Christopher J. Halbrook, University of California Irvine, Irvine, California


Getting Tenure

Zobeida Cruz-Monserrate, The Ohio State University Wexner Medical Center, Columbus, Ohio
Rushika M. Perera, University of California San Francisco, San Francisco, California


Balancing Clinical and Research Life

Susan Tsai, Medical College of Wisconsin, Wauwatosa, Wisconsin
Additional mentor to be announced


Mentoring the Mentor

Howard C. Crawford, Henry Ford Pancreatic Cancer Center, Detroit, Michigan
Additional mentor to be announced

Break
2-2:15 p.m.
Session 2: Big Data
Moderator: Jen Jen Yeh, University of North Carolina, Chapel Hill, North Carolina
2:15-4 p.m.

Session Keynote
Proteogenomic characterization of pancreatic ductal adenocarcinoma
Hui Zhang, Johns Hopkins University, Baltimore, Maryland

Four short talks from proffered abstracts

Discussant: Eric A. Collisson, University of California San Francisco, San Francisco, California

Discussion

Thursday, September 30

Keynote Lecture
10-10:45 a.m.

Key components for making impactful research advances in pancreatic cancer: A passionate team, a shared vision, and cutting-edge translational science
Jennifer B. Permuth, H. Lee Moffitt Cancer Center, Tampa, Florida

Break
10:45-11 a.m.
Session 3: Metabolism and Ras Signaling
Moderator: Andrew M. Lowy, University of California San Diego, La Jolla, California
11 a.m.-12:45 p.m.

Session Keynote
Metabolic stress in pancreatic cancer progression and therapy
Cosimo Commisso, Sanford Burnham Prebys Medical Discovery Institute, San Diego, California

Four short talks from proffered abstracts

Discussant: Donita Brady, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Discussion

Break
12:45-1:15 p.m.
Session 4: Tumor Microenvironment
Moderator: Pasca Di Magliano, University of Michigan Medical School, Ann Arbor, Michigan
1:15-3 p.m.

Session Keynote:
Rebalancing dysregulated tumor microenvironments in pancreatic cancer progression
Rosandra N. Kaplan, National Cancer Institute, Bethesda, Maryland

Four short talks from proffered abstracts

Discussant: Mara H. Sherman, OHSU Knight Cancer Center, Portland, Oregon

Discussion

Break
3-3:15 p.m.
Debate: The KPC Model Has Helped to Advance Pancreatic Cancer Therapy: Agree or Disagree?
Moderator: Anirban Maitra, UT MD Anderson Cancer Center, Houston, Texas
3:15-4 p.m.

Kenneth P. Olive, Herbert Irving Comprehensive Cancer Center, New York, New York
Phoebe Phillips, University of New South Wales, Sydney, Australia

Discussion

Closing Statements
4:15-4:20 p.m.